North America Non-Alcoholic Steatohepatitis Market
非酒精性脂肪性肝炎 (NASH) 是一种潜在的致命疾病，会导致肝脏出现广泛的疤痕和肝硬化。非酒精性脂肪肝病（NAFLD）是北美最常见的慢性肝病。 NASH是NAFLD的一种进行性形式，逐渐成为终末期肝病和肝移植的主要原因。根据全球肝脏研究所2019年6月12日公布的数据，非酒精性脂肪性肝炎（NASH）已被称为流行病。此外，它是一种进行性非酒精性脂肪肝病 (NAFLD)，影响约 1.15 亿人，到 2030 年，预计将有 3.57 亿人受到影响。肥胖、2 型糖尿病和高脂血症是 NAFLD 和 NASH 的重要危险因素：约 70% 以上的人肥胖，约 75% 患有 2 型糖尿病，20-80% 患有高脂血症。 NASH 如果不及时治疗，可能会发展为肝硬化、肝癌，甚至需要进行肝移植。根据美国肝脏基金会公布的数据，NAFLD 是美国最常见的慢性肝病。据预测，美国约 25% 的成年人患有 NAFLD，其中约 20% 患有 NASH，即美国成年人的 5%。根据 NASH 教育计划，2015 年至 2030 年间，NASH 患病率预计将增加 63%。2020 年至 2025 年间，NASH 预计将成为美国肝移植的主要原因。美国肝病研究协会于 2018 年发表报告，利用马尔可夫模型预测到 2030 年 NAFLD 疾病，并观察到 NAFLD 和 NASH 病例的患病率预计将分别增加 21% 和 63%，提供 33.5% 和成人 NAFLD 和 NASH 患病率分别为 27%。尽管 NAFLD/NASH 的患病率不断增加，但它仍然是一种未被充分认识的疾病，早期发现对于降低进展风险及其相关后果至关重要。因此，NASH 患病率的不断增长预计将推动非酒精性脂肪性肝炎 (NASH) 市场。预计北美非酒精性脂肪性肝炎市场在预测期内将以良好的复合年增长率增长。
< /p>
北美非酒精性脂肪性肝炎市场细分
北美非酒精性脂肪性肝炎市场细分深入了解产品、应用、销售渠道和国家。根据产品类型，北美非酒精性脂肪性肝炎市场分为维生素 E 和吡格列酮、ocaliva、elafibranor、selonsertib、cenicriviroc 等。 selonsertib 和cenicriviroc 细分市场预计将成为预测期内增长最快的细分市场。根据北美非酒精性脂肪性肝炎市场的应用，细分为治疗和诊断。 2020年，治疗细分市场在北美非酒精性脂肪性肝炎市场中占据主导地位。根据销售渠道，北美非酒精性脂肪性肝炎市场分为医院药房、在线供应商和零售药房。 2020年，零售药房领域在北美非酒精性脂肪性肝炎市场中占据主导地位。根据国家/地区，北美非酒精性脂肪性肝炎市场分为美国、墨西哥和加拿大。 2020年，美国主导北美非酒精性脂肪性肝炎市场。
Cadila Pharmaceutical、Intercept Pharmaceutical、Novartis AG、Galmed Pharmaceutical、GENFIT 、Prometheus Laboratories、Siemens Healthineers AG 和 Laboratory Corporation of America 是北美非酒精性脂肪性肝炎市场的领先公司。
Strategic insights for North America Non-Alcoholic Steatohepatitis involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 838.07 Million |
| Market Size by 2028 | US$ 12,963.42 Million |
| Global CAGR (2021 - 2028) | 47.9% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 北美
|
| Market leaders and key company profiles |
The regional scope of North America Non-Alcoholic Steatohepatitis refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The North America Non-Alcoholic Steatohepatitis Market is valued at US$ 838.07 Million in 2021, it is projected to reach US$ 12,963.42 Million by 2028.
As per our report North America Non-Alcoholic Steatohepatitis Market, the market size is valued at US$ 838.07 Million in 2021, projecting it to reach US$ 12,963.42 Million by 2028. This translates to a CAGR of approximately 47.9% during the forecast period.
The North America Non-Alcoholic Steatohepatitis Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Non-Alcoholic Steatohepatitis Market report:
The North America Non-Alcoholic Steatohepatitis Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Non-Alcoholic Steatohepatitis Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Non-Alcoholic Steatohepatitis Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Non-Alcoholic Steatohepatitis Market
